Diversified Trust Co trimmed its position in shares of GMO U.S. Quality ETF (NYSEARCA:QLTY – Free Report) by 6.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 193,111 shares of the company’s stock after selling 14,277 shares during the period. Diversified Trust Co’s holdings in GMO U.S. Quality ETF were worth $6,987,000 at the end of the most recent reporting period.
Separately, Aspen Investment Management Inc lifted its stake in GMO U.S. Quality ETF by 4.6% in the first quarter. Aspen Investment Management Inc now owns 27,800 shares of the company’s stock worth $1,006,000 after acquiring an additional 1,210 shares during the last quarter. Institutional investors and hedge funds own 85.37% of the company’s stock.
GMO U.S. Quality ETF Price Performance
NYSEARCA QLTY opened at $41.12 on Friday. GMO U.S. Quality ETF has a 52 week low of $32.63 and a 52 week high of $41.90. The stock has a market capitalization of $4.27 billion, a PE ratio of 57.11 and a beta of 0.98. The firm has a 50 day moving average of $40.36 and a two-hundred day moving average of $39.03.
GMO U.S. Quality ETF Company Profile
The GMO U.S. Quality ETF (QLTY) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund that focuses on equities of high-quality US companies. The funds investments may include companies of any market capitalization. QLTY was launched on Nov 13, 2023 and is issued by GMO.
Read More
- Five stocks we like better than GMO U.S. Quality ETF
- SpaceX Was Just the Beginning—2 More Massive IPOs Are on Deck
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
Want to see what other hedge funds are holding QLTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GMO U.S. Quality ETF (NYSEARCA:QLTY – Free Report).
Receive News & Ratings for GMO U.S. Quality ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Quality ETF and related companies with MarketBeat.com's FREE daily email newsletter.
